GlassScriptPhysician profile
Mithun Shenoi
NPI 1336482496
$5,341.16
in general payments reported to CMS, 2019-2025
15 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 81% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,017 · 2020: $73.79 · 2021: $99.59 · 2022: $17.75 · 2023: $135 · 2024: $1,167 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,029 · Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,028.91 |
| Food and Beverage | $1,104.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,873.12 | 2019-2022 | |
| Medtronic, INC. | $1,023.70 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $912.01 | 2025 | Axonics |
| Thd America, INC. | $854.86 | 2025 | |
| Axonics, INC. | $177.63 | 2024 | Axonics |
| Stryker Corporation | $152.52 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $120.18 | 2019 | |
| Merck Sharp & Dohme LLC | $60.11 | 2023 | Dificid |
| Acera Surgical, INC. | $49.78 | 2019-2020 | |
| Ethicon US, LLC | $30.30 | 2025 | Echelon Circular |
| Olympus America INC. | $27.17 | 2025 | Olympus, Hanarostent Biliary (Nnn), Disposable Biopsy Forceps |
| Braintree Laboratories, INC. | $22.49 | 2023 | Sutab |
| Janssen Pharmaceuticals, INC | $17.85 | 2023 | Xarelto |
| Hollister Incorporated | $12.59 | 2019 | |
| Phathom Pharmaceuticals, INC. | $6.85 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithun Shenoi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.